How Cash-Pay vs. Medical Mix Changes the Number
Why the split between cosmetic, cash-pay work and reimbursed medical dermatology moves your multiple in opposite directions.
Run the estimator →
Home / Who We Serve / Cosmetic Dermatology
Tier-1 Specialty · Sell-Side M&A
Sell Your Cosmetic Dermatology Practice for What Its Cash-Pay Demand Is Worth
Aesthetic Brokers runs a confidential, sell-side-exclusive sale process that positions your non-invasive procedure mix in front of the investors who pay the most for it. You represent the practice. We represent only you.
What's your cosmetic dermatology practice actually worth?
A confidential ballpark in under two minutes, no email required.
Why Cosmetic Dermatology Is Different
Why a Cosmetic Dermatology Practice Is Valued Differently
A cosmetic dermatology practice is valued on a different lever than most medical specialties: the share of revenue that comes from non-invasive, cash-pay procedures. Injectables, laser therapy, and other minimally invasive treatments carry consistent demand and low downtime, and that predictable, payor-independent cash flow is exactly what investment firms are paying a premium for. The more of your revenue that sits in this high-demand, repeat-visit category, the higher the multiple a buyer will support.
The second lever is whether that revenue holds together without you. Investors are drawn to cosmetic dermatology because the model is scalable and patient loyalty is strong, but a practice that runs on one owner-provider carries key-person risk that pulls value down. Aesthetic Brokers evaluates your market value, prepares the operation so demand and provider relationships transfer cleanly, and connects you only with buyers who understand what a cosmetic-heavy practice is actually worth.
Cash-Pay Procedure Mix
The greater the share of revenue from non-invasive, cash-pay treatments like injectables and laser therapy, the more predictable your income looks to a buyer. Payor-independent demand with low downtime is the single largest reason cosmetic dermatology earns toward the top of its range.
Provider Retention, Low Owner-Dependence
A buyer is acquiring future cash flow, not just this year's. Practices where associate providers carry the clinical load, backed by forward employment agreements, transfer cleanly and earn a higher multiple than a practice that depends on the founder behind every chair.
A Scalable, Non-Surgical Model
Adding treatments or locations in cosmetic dermatology is far more cost-effective than expanding a surgical center. That low cost to scale, paired with strong repeat business from satisfied patients, is what makes the model attractive to investors planning long-term growth.
Patient Loyalty and Technology Position
Repeat visits from loyal patients create steady, long-term revenue, and current laser and device technology signals that demand will hold. A practice with a retained patient base and modern equipment reads as durable, which protects value through a buyer's diligence.
| Owner-dependent, single site | One owner-provider performs most treatments; mostly cash-pay but concentrated; limited documented systems | Lower end of 3x – 15x |
| Provider-backed, systematized | Associate providers carry clinical load; strong patient retention; clean financials; documented operations | Middle of 3x – 15x |
| Cosmetic-heavy / multi-site platform | High non-invasive cash-pay mix, deep provider bench, multiple locations with central admin | Upper end of 3x – 15x |
Illustrative bands only. Where a cosmetic dermatology practice lands depends on its cash-pay mix, provider depth, and scale. Bands are built from published industry M&A benchmarks, not a sourced figure for your practice. Your real number comes from a confidential, practice-specific analysis.
How Value Is Built
We publish the framework, then tighten it for you.
The pattern is consistent: a high non-invasive cash-pay mix and a provider bench that runs without the founder move a cosmetic dermatology practice from a great job to an investable company. Your confidential report normalizes your earnings, applies your real comps, and shows exactly which moves widen the spread in your favor.
Run my numbers →See Your Number First
Know your number before anyone else does.
A confidential ballpark in under two minutes. No email required to see your range. The estimate is generated on your device. Nothing is stored or sent unless you choose to continue.
Step 1 · Instant ballpark
$3.0M
Estimated enterprise value
$1.4M – $4.7M
Practices like yours trade around 2.6x – 5.3x adjusted earnings.
What raises your number
- Build recurring revenue past 30% of sales
- Reduce owner-performed treatment dependence
- Clean, normalized three-year financials
What lowers your number
- Owner performs the majority of clinical work
- Recurring revenue under 15% of sales
Step 2 · What you receive when you continue
Your custom valuation report. Comparable transactions, your likely buyer pool, and timing analysis.
Your buyer-readiness scorecard. The specific moves that raise your multiple before you go to market.
A confidential 30-minute strategy call with Bill Walker. No obligation, no pressure.
Your information is never shared, and we have never broken a client's confidentiality.
Estimate only. A ballpark from limited inputs plus published industry M&A benchmarks.
Cosmetic Dermatology Sellers Ask
Everything that moves your number, in plain English.
Preparing Provider Agreements Before You Sell
How forward employment agreements with associate providers protect value and reduce a buyer's key-person concern.
Protect your value →Getting a Confidential Valuation First
How to learn where your practice stands without any information reaching a buyer, staff, or competitor.
Read your range →What Private Equity Actually Pays For
Which parts of your practice investment firms reward, and which ones they discount during diligence.
See what buyers value →Single Location vs. Multi-Site Value
How scale, central administration, and documented systems change what a buyer will support.
Scale-to-sell playbook →Timing Your Sale Around Demand and Technology
How current non-invasive demand and your equipment position factor into when to bring the practice to market.
Test the timing →Cosmetic Dermatology Track Record · Anonymized
Discretion is the proof.
Single-location Cosmetic Derm
$00.0M
Sell-side advisor
Cash-pay-led Cosmetic Derm
$00.0M
Sell-side advisor
Multi-site Cosmetic Derm
$00.0M
Sell-side advisor
Derm + Injectables Clinic
$00.0M
Sell-side advisor
Tombstone values redacted by design. The published board uses Aesthetic Brokers' verified, client-consented anonymized deals only.
Cosmetic Dermatology M&A · Vertical Intelligence
What Makes Selling a Cosmetic Dermatology Practice Different
Cosmetic dermatology is not a med spa with a physician badge. The buyer pool is different, the diligence questions are different, and the things that protect or erase value are specific to this vertical. A generalist broker typically treats it like any other cash-pay practice. Here is what that misses.
Buyers Are Buying Your Referral Network, Not Just Your Revenue
A cosmetic dermatology practice holds something a med spa rarely does: an active, physician-sourced referral network. Primary care physicians, plastic surgeons, and aestheticians route patients to a dermatologist they trust by name. That network is durable, hard to replicate, and exactly what a strategic acquirer or PE platform is pricing into your deal. Generalist brokers present your revenue. We present your referral depth, your physician relationships, and how those relationships continue after you step back. The difference in how a buyer reads those two stories shows up in the offer.
Physician Concentration Is the Most Common Value Discount in This Vertical
Buyers pricing a cosmetic dermatology practice ask one question before almost any other: if the selling physician leaves, how much revenue stays? When the answer is "not much," the buyer applies a key-person discount that meaningfully reduces what they will pay. This is the single largest source of value destruction we see in cosmetic derm transactions. We build your sale narrative around the practice, not the person. That means documenting patient database retention, associate provider relationships, and documented treatment protocols so the business reads as transferable, not as a physician's private practice with a buyer's name on the door.
The Cash-Pay Share Matters More Here Than in Almost Any Other Specialty
In most medical specialties, payor mix is a compliance question. In cosmetic dermatology, it is a valuation question. The greater the share of your revenue that comes from non-invasive, cash-pay procedures such as injectables, laser resurfacing, and body contouring, the more predictable and payor-independent your income looks to a buyer. Two practices with identical revenue can be worth different amounts depending on how much of that revenue is cash-pay versus reimbursed medical dermatology. We know where the value line sits, and we build your positioning around pushing it up, not averaging it away.
What a Specialist Sees That a Generalist Broker Misses
Cosmetic dermatology is currently one of the most active verticals in medical-aesthetic M&A. National derm consolidators and PE-backed platforms are building practices at scale, and they come to the table with a prepared playbook and experienced advisors. A generalist broker typically prices a practice against general medical practice comps, misses the vertical premium available in this consolidation environment, and underweights the factors buyers in this space actually pay for. Aesthetic Brokers works exclusively in the medical-aesthetic space. We know which buyers are building derm platforms right now, what their quality-of-earnings teams focus on, and how to present your cash-pay mix, your provider bench, and your patient retention in a way that supports the strongest offer the market will bear. We do not publish an invented multiple as the honest anchor for your practice. Your actual number comes from a confidential, practice-specific analysis built on your real economics and current buyer activity.
Cosmetic Dermatology Sale FAQ
Straight answers, before you commit to anything.
A cosmetic dermatology practice is valued on its adjusted earnings, with a multiple applied on top. We start from your true bottom-line profitability, then move the multiple up or down based on your cash-pay procedure mix, provider retention, patient loyalty, and scale. A higher share of non-invasive, cash-pay revenue and lower dependence on the owner support a higher multiple, which is why two practices with the same revenue can be worth very different amounts.
Cash-pay, non-invasive treatments like injectables and laser therapy carry consistent patient demand with little downtime, and that income is predictable and independent of insurance reimbursement. Investment firms pay a premium for that durability. The larger the share of your revenue from this high-demand category, the higher the multiple a buyer will support, which is what pushes cosmetic dermatology toward the top of its range.
Yes. A valuation begins with a confidential consultation, and no information is shared with any buyer until you decide you are ready. We give you the same view a buyer’s quality-of-earnings team would have, but privately and on your terms. Many owners get a valuation simply to know where they stand, with no obligation to sell, the same way you would get an annual health checkup.
No, not unless and until you choose to tell them. We treat confidentiality as a core part of protecting your value. Premature disclosure can unsettle staff, shake patient confidence, and weaken your negotiating position, so we control the flow of information with confidentiality agreements, secure data rooms, and a vetted buyer process. You decide what is shared, with whom, and when.
No. We are sell-side-exclusive, which means we represent the practice owner, never the buyer, in your transaction. Private equity firms and strategic acquirers come to the table with their own advisors and a practiced playbook. Our role is to be the experienced team in your corner so the deal is structured around your goals, your providers, and your number, not theirs.
Yes, often significantly. A buyer is acquiring future cash flow, so a practice that depends on the owner-provider for most treatments carries key-person risk, which is the most common discount we see. When associate providers carry the clinical load under forward employment agreements, the practice transfers cleanly and earns a meaningfully higher multiple.
Who you work with
You are advised by Bill Walker, not handed to a junior associate.
Bill Walker founded Aesthetic Brokers after leading mergers and acquisitions for a large private-equity-backed healthcare services organization. Before that he flew for the Marine Corps at the Presidential Helicopter Squadron and commanded a squadron in combat. He knows how an investor values a practice, and how to make sure that value lands with you, not the buyer.
Talk with Bill about your practiceYour cosmetic dermatology practice deserves an uncommon partner.
Start with a confidential, two-minute read on where you stand.